EE40 Identifying and Quantifying Elements of Value for Nivolumab and Ipilimumab in First-Line Non-Small Cell Lung Cancer
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.346
https://www.valueinhealthjournal.com/article/S1098-3015(23)00446-1/fulltext
Section Title :
Section Order :
11729
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00446-1&doi=10.1016/j.jval.2023.03.346